Search Index

Characteristics, triggers and theoretical models of embarrassment Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Psychology of embarrassment: why do we get embarrassed? 05/06/25, 10:07 Last updated: Published: 06/09/24, 11:07 Characteristics, triggers and theoretical models of embarrassment The six basic emotions proposed by Ekman and recognised worldwide are sadness, happiness, fear, anger, surprise and disgust- Ekman (1999). Recently, the list of basic emotions has expanded to include self-conscious emotions, such as embarrassment, pride and shame, as all of those emotions show evidence for cross-cultural and cross-species production and perception. According to Miller (1995), embarrassment is the self-conscious feeling individuals get after realising they have done something stupid, silly or dishonourable. Embarrassment is a social emotion that emerges at around 18 months of age and the development of which is related to self-recognition. Characteristics of embarrassment in humans are gaze aversion, downward head movements, controlled smile and face touching. Embarrassment has been linked to the two main personality dimensions proposed by Eysenck (1983): extraversion/introversion and neuroticism/emotional stability. Kelly & Jones (1997) found that neuroticism is positively associated with embarrassment, suggesting that the individuals who score highly in neuroticism are more prone to experiencing embarrassment. The same researchers also concluded that embarrassment is negatively related to extraversion, implying that introverted individuals are more likely to feel embarrassed than extroverted individuals. The three triggers of embarrassment, according to Sabini, Siepmann & Meyerowitz (2000), are faux pas, sticky situations and centre of attention. Faux pas causes embarrassment when an individual creates a social mistake that forces them to think of others’ evaluation, like misspelling a word in a presentation and only realising when presenting it to a supervisor. Sticky situations lead to embarrassment when they threaten an individual's role, not their self-esteem, such as a leader being challenged publicly by their second in command. Centre of attention describes an anomaly when embarrassment is not a result of failure but of increased attention, for example being at your own birthday party. The faux pas trigger aligns with the social evaluation model of embarrassment, whilst sticky situations are in line with the dramaturgic model of embarrassment. There are four prominent theories of embarrassment: the dramaturgic model, the social evaluation model, the situational self-esteem model and the personal standards model. The dramaturgic model proposed by Silver, Sabini and Parrott (1987) says that embarrassment is the flustered uncertainty that follows a poor public performance and leaves the individual at a loss of what to do. This model suggests that anxiety and aversive arousal trigger embarrassment after realising a performance has gone wrong (see Figure 4 ). In this model, concern about what others think accompanies embarrassment but does not cause it. Miller (1996) suggests that whilst the dramaturgic model has substantial support, it is difficult for a dramaturgic dilemma to cause embarrassment without simultaneously creating unwanted social evaluations, highlighting a limitation of this model. The social evaluation model of embarrassment put forward by Edelmann (1987) suggests that embarrassed individuals fear failure to impress others and feeling at a loss of what to do is a result of embarrassment, not the cause (see Figure 5 ). This model assumes that individuals are concerned about others’ opinions. Miller (1996) supports this theory, saying that negative evaluation from others is crucial to embarrassment. The situational self-esteem model by Modigliani (1971) proposes that the root cause of embarrassment is the temporary loss of self-esteem that results from public failures based on one’s own opinions of self and performance in faulty situations (see Figure 6). Miller (1995) does not support this theory, arguing that self-esteem plays a secondary role in embarrassment and states that susceptibility to embarrassment depends more on the persistent concern about others’ evaluations of us. The personal standards model of embarrassment introduced by Babcock (1988) presents the view that embarrassment is caused by the individual realising they have failed the standards of behaviour that they have set for themselves, implying that the situation does not matter and that individuals can feel embarrassment when they are alone (see Figure 7 ). Miller (1992) disagrees with this theory, saying that guidelines for self are linked to impressions made on other people and that embarrassment can happen due to poor audience reaction, not letting yourself down. Therefore, there are many plausible theories behind embarrassment that have been linked to various causes like dispositional, situational and personality factors. Whilst it is unlikely that one theory can perfectly explain such a complex social emotion like embarrassment, the consensus among psychologists in the recent years has created the most support for a combination of the dramaturgic and the social evaluation models. I agree with the consensus and think that the different theories behind embarrassment may all apply to a given situation. For instance, forgetting someone’s name may lead to embarrassment due to being at a loss of what to say (the dramaturgic model), unwanted social judgements (the social evaluation model), the negative effects of this situation on the self-esteem (the situational self-esteem model) and the painful realisation of letting yourself down (the personal standards model). Thus, like many subjects in psychology, embarrassment is a multidimensional concept that can be looked at from many different angles. Written by Aleksandra Lib Related articles: Chemistry of emotions / Unmasking aggression / Inside out: chemistry of depression REFERENCES Babcock, M. K. (1988). Embarrassment: A window on the self. Journal for the Theory of Social Behaviour . Edelmann, R. J. (1987). The psychology of embarrassment . John Wiley & Sons. Ekman, P. (1999). Basic emotions. Handbook of cognition and emotion , 98 (45-60), 16. Eysenck, H. J. (1983). Psychophysiology and personality: Extraversion, neuroticism and psychoticism. In Individual differences and psychopathology (pp. 13-30). Academic Press. Kelly, K. M., & Jones, W. H. (1997). Assessment of dispositional embarrassability. Anxiety, Stress, and Coping, 10 (4), 307-333. Lewis, M., Sullivan, M. W., Stanger, C., & Weiss, M. (1989). Self development and self-conscious emotions. Child development , 146-156. Miller, R. S. (1992). The nature and severity of self-reported embarrassing circumstances. Personality and Social Psychology Bulletin , 18 (2), 190-198. Miller, R. S. (1995). On the nature of embarrassabllity: Shyness, social evaluation, and social skill. Journal of personality , 63 (2), 315-339. Miller, R. S. (1996). Embarrassment: Poise and peril in everyday life. Guilford Press. Modigliani, A. (1971). Embarrassment, facework, and eye contact: Testing a theory of embarrassment. Journal of Personality and social Psychology , 17 (1), 15. Sabini, J., Siepmann, M., Stein, J., & Meyerowitz, M. (2000). Who is embarrassed by what?. Cognition & Emotion , 14 (2), 213-240. Silver, M., Sabini, J., Parrott, W. G., & Silver, M. (1987). Embarrassment: A dramaturgic account. Journal for the Theory of Social Behaviour , 17 (1), 47-61. Tracy, J. L., Robins, R. W., & Tangney, J. P. (2007). The self-conscious emotions. New York: Guilford . Project Gallery

How can patients with metastasised cancer be treated? Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cancer on the Move 09/07/25, 13:31 Last updated: Published: 30/01/24, 19:57 How can patients with metastasised cancer be treated? Introducing and Defining Metastasis Around 90% of patients with cancer die due to their cancer spreading (metastasis). Despite its prevalence, many critical questions remain in the field of cancer research about how and why cancers metastasise. The metastatic cascade has three main steps: dissemination, dormancy, and colonisation. Most cells that disseminate die once they leave the primary tumour, thus, posing an evolutionary bottleneck. However, the few that survive will face another challenge of entering a foreign microenvironment. Those circulating tumour cells (CTCs) acquire a set of functional abilities through genetic alterations, enabling them to survive the hostile environment. CTCs can travel as single cells or as clusters. If they travel in clusters, CTCs can be coated with platelets, neutrophils, and other tumour-associated cells, protecting CTCs from immune surveillance. As these CTCs travel further, they are named disseminated tumour cells (DTCs). These cells are undetectable by clinical imaging and can enter a state of dormancy. The metastatic cascade represents ongoing cellular reprogramming and clonal selection of cancer cells that can withstand the hostile external environment. How does metastasis occur, and what properties allow these cancer cells to survive? How & Why Does Cancer Metastasise? The Epithelial-to-Mesenchymal Transition (EMT) is a theory that explains how cancer cells can metastasise. In this theory, tumour cells lose their epithelial cell-to-cell adhesion and gain mesenchymal migratory markers. Tumour cells that express a mixture of epithelial and mesenchymal properties were found to be the most effective in dissemination and colonisation to the secondary site. It is important to note that evidence for the EMT has been acquired predominantly in vitro , where additional in vivo research is necessary to confirm this phenomenon. Nevertheless, although EMT does not accurately address why cancers metastasise, it provides a framework for how a cancer cell develops the properties to metastasise. Many factors contribute to why cancers metastasise. For example, a lack of blood supply, which occurs when a cancer grows too large, causes the cells in the centre to lack access to the oxygen carried by red blood cells. Thus, to evade cell death, cancer cells detach from the primary tumour to regain access to oxygen and nutrients. In addition, cancer cells exhibit a high rate of glycolysis to supply sufficient energy for its uncontrollable proliferation. However, this generates lactic acid as a by-product, resulting in a low pH environment. This acidic pH environment stimulates cancer invasion and metastasis as cancer cells move away from this hostile environment to evade cell death once again, an effect referred to as the ‘Warburg Effect’. In Figure 2, you can see that multiple interplaying factors that contribute to metastasis. So, how can patients with metastasised cancer be treated? Current Treatments and Biggest Challenges? Depending on what stage the patient presents at and what cancer type, the treatment options differ. Figure 3 shows an example of these treatment plans. For early stages I and II, chemotherapy and targeted treatments are offered, and in specific cases, local surgery is done. These therapies are done to slow the growth of the cancer or lessen the side effects of treatments. An example of treating metastasised prostate cancer includes hormone therapy, as the cancer relies on the hormone testosterone to grow. Currently, cytotoxic chemotherapy remains the backbone of metastatic therapy. However, there are emerging immunotherapeutic treatments under trial. These aim to boost the ability of the immune system to detect and kill cancer cells. Hopefully, these new therapies may improve the prognosis of metastatic cancers when used in complement with conventional therapies, shining a new light into the therapeutic landscape of advanced cancers. Future Directions Recent developments have opened new avenues to discovering potential treatment targets for metastatic cancer. The first is to target the dormancy of DTCs, where the role of the immune system plays an important part. Neoadjuvant ICI (immune checkpoint inhibitor) studies are anticipated to provide insight into novel biomarkers and can eliminate micro-metastatic cancer cells. Also, using novel technology such as single-cell RNA sequencing reveals complex information about the plasticity of metastatic cancer cells, allowing researchers to understand how cancer cells adapt in stressful conditions. Finally, in vivo models, such as patient-derived models, could provide crucial insight into future treatments as they reproduce the patients’ reactions to different drug treatments. There are many limitations and challenges to the research and treatment of cancer metastasis. It is clear, however, that with more studies into the properties of metastatic cancers and the different avenues of novel targets and therapeutics, there is a promising outcome in the field of cancer research. Written by Saharla Wasame Related articles: Immune signals and metastasis / Cancer magnets for tumour metastasis / Brain metastasis / Novel neuroblastoma driver for therapeutics REFERENCES Fares, J., Fares, M.Y., Khachfe, H.H., Salhab, H.A. and Fares, Y. (2020). Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduction and Targeted Therapy , 5(1). doi: https://doi.org/10.1038/s41392-020-0134-x . Ganesh, K. and Massagué, J. (2021). Targeting metastatic cancer. Nature Medicine , 27(1), pp.34–44. doi: https://doi.org/10.1038/s41591-020-01195-4 . Gerstberger, S., Jiang, Q. and Ganesh, K. (2023). Metastasis. Cell , [online] 186(8), pp.1564–1579. doi: https://doi.org/10.1016/j.cell.2023.03.003 . Li, Y. and Laterra, J. (2012). Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes? Cancer Research , [online] 72(3), pp.576–580. doi: https://doi.org/10.1158/0008-5472.CAN-11-3070 . Liberti, M.V. and Locasale, J.W. (2016). The Warburg Effect: How Does it Benefit Cancer Cells? Trends in Biochemical Sciences , [online] 41(3), pp.211–218. doi: https://doi.org/10.1016/j.tibs.2015.12.001 . Mlecnik, B., Bindea, G., Kirilovsky, A., Angell, H.K., Obenauf, A.C., Tosolini, M., Church, S.E., Maby, P., Vasaturo, A., Angelova, M., Fredriksen, T., Mauger, S., Waldner, M., Berger, A., Speicher, M.R., Pagès, F., Valge-Archer, V. and Galon, J. (2016). The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Science Translational Medicine , 8(327). doi: https://doi.org/10.1126/scitranslmed.aad6352 . Oscar Hernandez Dominguez, Yilmaz, S. and Steele, S.R. (2023). Stage IV Colorectal Cancer Management and Treatment. Journal of Clinical Medicine , 12(5), pp.2072–2072. doi: https://doi.org/10.3390/jcm12052072 . Steeg, P.S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nature Medicine , [online] 12(8), pp.895–904. doi: https://doi.org/10.1038/nm1469 . Project Gallery

Looking at p53 mutations and cancer predisposition Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Decoding p53: the guardian against cancer 09/07/25, 14:03 Last updated: Published: 23/11/23, 11:38 Looking at p53 mutations and cancer predisposition Being a tumour suppressor protein, p53 encoded by the TP53 gene plays a critical role in regulating cell division and preventing the formation of tumours. Its function in maintaining genome stability is vital in inhibiting cancer development. Understanding p53 Located on chromosome locus 17p13.1, TP53 encodes the p53 transcription factor 1. Consisting of three domains, p53 can directly initiate or suppress the expression of 3661 different genes involved in cell cycle control and DNA repair 2. With this control, p53 can influence cell division on a massive scale. Cancer is characterised by uncontrolled cell division, which can occur due to accumulated mutations in either proto-oncogenes or tumour suppressor genes. Wild-type p53 can repair mutations in oncogenes such that they will not affect cell division. However, if p53 itself is mutated, then its ability to repair DNA and control the cell cycle is inhibited, leading to the emergence of cancer. Mutations in TP53 are actually the most prevalent genetic alterations found in patients with cancer. The mechanisms by which mutated p53 leads to cancer are manifold. One such mechanism is p53’s interaction with p21. Encoded by CDKN1A , p21 is activated by p53 and prevents cell cycle progression by inhibiting the activity of cyclin-dependent kinases (CDKs). Therefore, we can see that a non-functional p53 would lead directly to uncontrolled cell division and cancer. Clinical significance The importance of p53 in preventing cancer is highlighted by the fact that individuals with inherited TP53 mutations (a condition known as Li-Fraumeni syndrome or LFS) have a significantly greater risk of developing any cancer. These individuals inherit one defective TP53 allele from one parent, making them highly susceptible to losing the remaining functional TP53 allele, ultimately leading to cancer. Loss of p53 also endows cells with the ability to ignore pro-apoptotic signals such that if a cell becomes cancerous, it is far less likely to undergo programmed cell death 3. Its interactions with the apoptosis-inducing proteins Bax and Bak, are lost when mutated, thus leading to cellular apoptosis resistance. The R337H mutation in TP53 is an example of the founder effect at work. The founder effect refers to the loss of genetic variation when a large population descends from a smaller population of fewer individuals. The descendants of the initial population are much more likely to harbour genetic variations that are less common in the species as a whole. In southern Brazil, the R337H mutation in p53 is present at an unusually high frequency 4 and is thought to have been introduced by European settlers several hundred years ago. It is responsible for a widespread incidence of early-onset breast cancers, LFS, and paediatric adrenocortical tumours. Interestingly, individuals with this mutation can trace their lineage back to the group of European settlers that set foot in Brazil hundreds of years ago. Studying p53 has enabled us to unveil its intricate web of interactions with other proteins and molecules within the cell and unlock the secrets of cancer development and potential therapeutic strategies. By restoring or mimicking the functions of p53, we may be able to provide cancer patients with some relief from this life-changing condition. Written by Malintha Hewa Batage Related articles: Zinc finger proteins / Anti-freeze proteins Project Gallery

Through photonic integration Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The future of semiconductor manufacturing 11/07/25, 10:03 Last updated: Published: 22/12/23, 15:11 Through photonic integration Recently the researchers from the University of Sydney developed a compact photonic semiconductor chip by heterogeneous material integration methods which integrates an active electro-optic (E-O) modulator and photodetectors in a single chip. The chip functions as a photonic circuit (PIC) offering a 15 gigahertz of tunable frequencies with a spectral resolution of only 37 MHz and is able to expand the radio frequency bandwidth (RF) to precisely control the information flowing within the chip with the help of advanced photonic filter controls. The application of this technology extends to various fields: • Advanced Radar: The chip's expanded radio-frequency bandwidth could significantly enhance the precision and capabilities of radar systems. • Satellite Systems: Improved radio-frequency performance would contribute to more efficient communication and data transmission in satellite systems. • Wireless Networks: The chip has the potential to advance the speed and efficiency of wireless communication networks. • 6G and 7G Telecommunications: This technology may play a crucial role in the development of future generations of telecommunications networks. Microwave Photonics (MWP) is a field that combines microwave and optical technologies to provide enhanced functionalities and capabilities. It involves the generation, processing, and distribution of microwave signals using photonic techniques. An MWP filter is a component used in microwave photonics systems to selectively filter or manipulate certain microwave frequencies using photonic methods (see Figure 1 ). These filters leverage the unique properties of light and its interaction with different materials to achieve filtering effects in the microwave domain. They can be crucial in applications where precise control and manipulation of microwave signals are required. MWP filters can take various forms, including fiber-based filters, photonic crystal filters and integrated optical filters. These filters are designed to perform functions such as wavelength filtering, frequency selection and signal conditioning in the microwave frequency range. They play a key role in improving the performance and efficiency of microwave photonics systems. The MWP filter operates through a sophisticated integration of optical and microwave technologies as depicted in the diagram. Beginning with a laser as the optical carrier, the photonic signal is then directed to a modulator where it interacts with an input Radio-Frequency (RF) signal. The modulator dynamically influences the optical carrier's intensity, phase or frequency based on the RF input. Subsequently, the modulated signal undergoes processing to shape its spectral characteristics in a manner dictated by a dedicated processor. This shaping is pivotal for achieving the desired filtering effect. The processed optical signal is then fed into a photodiode for conversion back into an electrical signal. This conversion is based on the variations induced by the modulator on the optical carrier. The final output which is represented by the electrical signal reflects the filtered and manipulated RF signal which demonstrates the MWP's ability in leveraging both optical and microwave domains for precise and high-performance signal processing applications. Extensive research has been conducted in the field of MWP chips, as evidenced by a thorough examination in Table 1 . This table compares recent studies based on chip material type, filter type, on-chip component integration, and working bandwidth. Notably, previous studies demonstrated noteworthy advancements in chip research despite the dependence on external components. What distinguishes the new chip is its revolutionary integration of all components into a singular chip which is a significant breakthrough that sets it apart from previous attempts in the field. Here the term "On-chip E-O" involve the integration of electro-optical components directly onto a semiconductor chip or substrate. This integration facilitates the interaction between electrical signals (electronic) and optical signals (light) within the same chip. The purpose is to enable the manipulation, modulation or processing of optical signals using electrical signals typically in the form of voltage or current control. Key components of on-chip electro-optical capabilities include: 1. Modulators which alter the characteristics of an optical signal in response to electrical input which is crucial for encoding information onto optical signals. 2. Photonic detectors convert optical signals back into electrical signals extracting information for electronic processing. 3. Waveguides guide and manipulate the propagation of light waves within the chip, routing optical signals to various components. 4. Switches routes or redirects the optical signals based on electrical control signals. This integration enhances compactness, energy efficiency, and performance in applications such as communication systems and optical signal processing. "FSR-free operation" refers to Free Spectral Range (FSR) which is a characteristic of optical filters and resonators. FSR is the separation in frequency between two consecutive resonant frequencies or transmission peaks. The column "FSR-free operation" indicates whether the optical processing platform operates without relying on a specific or fixed Free Spectral Range. It means that its operation is not bound or dependent on a particular FSR. This could be advantageous in scenarios where flexibility in the spectral range or the ability to operate over a range of frequencies without being constrained by a specific FSR is desired. "On-chip MWP link improvement" refers to enhancements made directly on a semiconductor chip to optimize the performance of MWP links. These improvements aim to enhance the integration and efficiency of communication or signal processing links that involve both microwave and optical signals. The term implies advancements in key aspects such as data transfer rates, signal fidelity and overall link performance. On-chip integration brings advantages such as compactness and reduced power consumption. The manufacturing of the photonic integrated circuit (PIC) involves partnering with semiconductor foundries overseas to produce the foundational chip wafer. This new chip technology will play a crucial role in advancing independent manufacturing capabilities. Embracing this type of chip architecture enables a nation to nurture the growth of its autonomous chip manufacturing sector by mitigating reliance on international foundries. The extensive chip delays witnessed during the 2020 COVID pandemic underscored the global realization of the chip market's significance and its potential impact on electronic manufacturing. Written by Arun Sreeraj Related articles: Advancements in semi-conductor technology / The search for a room-temperature superconductor / Silicon hydrogel lenses / Mobile networks Project Gallery

Unlocking the potential to tackle plastic pollution in oceans Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Genetically-engineered bacteria break down plastic in saltwater 09/07/25, 14:14 Last updated: Published: 29/09/23, 20:19 Unlocking the potential to tackle plastic pollution in oceans Groundbreaking discovery in the fight against plastic pollution North Carolina State University researchers have made a groundbreaking discovery in the fight against plastic pollution in marine environments. They have successfully genetically engineered a marine microorganism capable of breaking down polyethylene terephthalate (PET), a commonly used plastic found in water bottles and clothing, contributing to the growing problem of ocean microplastic pollution. Introducing foreign enzymes to V. natriegens The modified organism, created by incorporating genes from the bacterium Ideonella sakaiensis into the genome of Vibrio natriegens , can effectively degrade PET in saltwater conditions. This achievement marks the first time foreign enzymes have been successfully expressed on the surface of V. natriegens cells, making it a significant scientific breakthrough. PET microplastics pose a significant challenge in marine ecosystems, and current methods of removing them, such as extracting and disposing of them in landfills, are not sustainable. The researchers behind this study aim to find a more environmentally friendly solution by breaking down PET into reusable products, like thermoformed packaging (takeaway cartons) or textiles (clothing, duvets, pillows, carpeting). The team worked with two bacteria species, V. natriegens and I. sakaiensis . V. natriegens , known for its rapid reproduction in saltwater, served as the host organism, while I. sakaiensis provided the enzymes necessary for PET degradation. The researchers first rinsed the plastics collected from the ocean to remove high-concentration salts before initiating the plastic degradation process. Challenges ahead While this breakthrough is a significant step forward, three key challenges are still ahead. The researchers aim to incorporate the DNA responsible for enzyme production directly into the genome of V. natriegens to enhance stability. Because DNA is the genetic material responsible for the production of enzymes, and enzymes are proteins that are responsible for carrying out various chemical reactions in the body, by incorporating the DNA responsible for enzyme production into the genome of V. natriegens , the researchers can enhance the stability of the enzyme production. Thus, this DNA is essential for producing the enzymes necessary for PET degradation, as it contains the genetic information vital for encoding the proteins needed for PET breakdown. Additionally, the research team plans to modify V. natriegens further to feed on the byproducts generated during PET degradation. Lastly, they seek to engineer V. natriegens to produce a desirable end product from PET, such as a molecule that can be utilised in the chemical industry. Collaboration with industry groups Collaboration with industry groups is also crucial in determining the market demand for the molecules that V. natriegens can produce. The researchers are open to working with industry partners to explore the vast production scale and identify the most desirable molecules for commercial use. By introducing the genes responsible for PET degradation into V. natriegens using a plasmid, the researchers successfully induced the production of enzymes on the surface of the bacterial cells. The modified V. natriegens demonstrated its ability to break down PET microplastics in saltwater, providing a practical and economically feasible solution for addressing plastic pollution in marine environments. This research represents a significant advancement in the field, as it is the first time that V. natriegens has been genetically engineered to express foreign enzymes on its cell surface. This breakthrough opens up possibilities for further modifications, such as incorporating the DNA from I. sakaiensis directly into the genome of V. natriegens to make the production of plastic-degrading enzymes a more stable feature of the organism. The researchers aim to modify V. natriegens to feed on the byproducts produced during the breakdown of PET and create a desirable end product for the chemical industry. The researchers are open to collaborating with industry groups to identify the most desirable molecules to be engineered into V. natriegens for production. This groundbreaking research, published in the AIChE Journal with the support of the National Science Foundation under grant 2029327, paves the way for developing more efficient and sustainable methods for addressing plastic pollution in saltwater environments. Conclusion The research has made a breakthrough in the fight against plastic pollution in marine environments. By incorporating genes from the bacterium I. sakaiensis into the genome of V. natriegens , they created a genetically modified marine microorganism capable of breaking down PET. This achievement provides a practical and economically feasible solution to address plastic pollution in aquatic ecosystems. The researchers are now looking into further modifications to the organism to enable it to feed on byproducts and to produce a desirable end product that can be used in the chemical industry. This research highlights the potential of genetic engineering to create sustainable solutions to the growing problem of plastic pollution. Written by Sara Maria Majernikova Related article: Plastics and their environmental impact Project Gallery

Unmasking the complexities of the condition Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Crohn's disease 09/07/25, 14:01 Last updated: Published: 22/03/24, 20:16 Unmasking the complexities of the condition Introduction Crohn's disease is a chronic inflammatory condition that primarily targets the gastrointestinal tract. While it commonly afflicts individuals aged 20 to 50, it can also manifest in children and older adults, albeit less frequently. Symptoms of Crohn's disease vary widely and may include skin lesions spanning from the mouth to the anus, along with prevalent issues such as diarrhoea, abdominal pain, weight loss, rectal bleeding, fatigue, and fever. Diagnosis Diagnosing Crohn's disease can be challenging due to its similarity to other conditions. However, specific symptoms like bloody diarrhoea, iron deficiency, and unexplained weight loss are significant indicators that warrant further investigation by a gastroenterologist. Many tests that can confirm Crohn’s disease: Endoscopy: endoscopy, including procedures like colonoscopy and upper endoscopy, is a dependable method for diagnosing Crohn's disease and distinguishing it from other conditions with similar symptoms. During an endoscopy, a thin tube called an endoscope is inserted into the rectum to visually inspect the entire gastrointestinal tract and collect small tissue samples for further analysis. Imaging: Computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography are valuable tools for assessing disease activity and detecting complications associated with Crohn's disease. These imaging techniques can examine areas of the gastrointestinal tract that may not be accessible via endoscopy, providing comprehensive insights into the condition's progression and associated issues. Laboratory testing: various laboratory tests, including complete blood count, C-reactive protein levels, pregnancy tests, and stool samples, are conducted to screen for Crohn's disease. These tests are typically the initial step in diagnosis, helping to avoid the necessity for more invasive procedures like endoscopies and imaging. Additionally, laboratory testing may involve assessing inflammatory markers such as erythrocyte sedimentation rate (ESR) and faecal calprotectin to further aid in diagnosis and monitoring of the condition. Treatment and prevention While there is currently no cure for Crohn’s disease, numerous treatments have been developed over time to effectively manage symptoms and sometimes even induce remission. When determining a treatment plan for patients, factors such as age, specific symptoms, and the severity of inflammation are taken into careful consideration. Corticosteroids and immunomodulators are medications commonly used to manage Crohn’s disease. Corticosteroids work by reducing inflammation and suppressing the immune system, typically employed to address flare-ups due to their rapid action. However, they are not suitable for long-term use as they may lead to significant side effects. In contrast, maintenance therapy often involves immunomodulators such as azathioprine, methotrexate, or biologic agents like anti-TNF drugs (such as infliximab or adalimumab). These medications target specific immune pathways to enhance the effectiveness of the immune system. Research indicates that immunomodulators are associated with fewer adverse effects compared to corticosteroids and are effective in maintaining remission. Monoclonal antibody treatment is another approach used to manage symptoms and sustain remission in Crohn's disease. These therapies are categorised as biologic treatments, targeting precise molecules involved in inflammation and the immune response. Despite carrying certain risks, such as infections, the likelihood of developing cancer with these treatments is typically deemed low. Crohn’s disease frequently leads to complications that may necessitate surgical intervention. Gastrointestinal surgeries can greatly alleviate symptoms and enhance the quality of life for patients. However, surgery is usually considered only when medical therapy proves insufficient in controlling the disease or when complications arise. Although the exact cause of Crohn’s disease remains uncertain, factors such as genetics, immune system dysfunction, and environmental influences are believed to contribute to its development. While there is no definitive evidence pinpointing specific causative factors, numerous studies suggest potential links to an unhealthy diet and lifestyle, dysbiosis (imbalance of healthy and unhealthy gut bacteria), smoking, and a family history of the disease. Therefore, it is crucial to minimise exposure to these risk factors in order to decrease the likelihood of developing Crohn’s disease. Written by Sherine Abdul Latheef Related articles: the gut microbiome / the dopamine connection / Diverticular disease / Mesenchymal stem cells REFERENCES Veauthier B, Hornecker JR. Crohn's Disease: Diagnosis and Management. Am Fam Physician. 2018;98(11):661-669. Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389(10080):1741-1755. doi:10.1016/S0140-6736(16)31711-1 Mills SC, von Roon AC, Tekkis PP, Orchard TR. Crohn's disease. BMJ Clin Evid. 2011;2011:0416. Published 2011 Apr 27. Sealife, A. (2024) Crohn’s disease, Parkland Natural Health. Available at: https://wellness-studio.co.uk/crohns-disease/ (Accessed: 09 March 2024). How to stop anxiety stomach pain & cramps (2022) Calm Clinic - Information about Anxiety, Stress and Panic. Available at: https://www.calmclinic.com/anxiety/symptoms/stomach-pain (Accessed: 09 March 2024). Project Gallery

Delving into the impacts of gut bacteria on health Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Gut Microbiome 11/07/25, 09:58 Last updated: Published: 04/04/24, 16:41 Delving into the impacts of gut bacteria on health Inflammatory Bowel Disease The microbiome is hugely important to human health, and has been shown to beneficial to digestion, the immune system and even our mental health when in good working condition. However, disruption to the balance of the microbial flora has likewise been associated with multiple diseases and poor general health. Dysbiosis, or a poor balance, of human microbiome communities has been implicated in a wide range of disease, such as cardiovascular disease, chronic inflammation, obesity and even mental health issues. A diverse and well-balanced microbial community is important for disease prevention, however modern over usage of antibiotics as well as poor diets low in dietary fibre and high in artificial additives can lead to compromised communities dominated by single pathogenic strains of bacteria. The human microbiome plays a critical role in overall health, from providing valuable metabolites to aiding the immune system. Friendly commensal bacteria colonise major regions in our gut, with characteristic diverse communities of microbes inhabiting them. These microbes occupy these niches and outcompete pathogenic organisms, actively preventing infection and disease. In this article we will be specifically looking into the link between the gut microbiome and Inflammatory Bowel disease (IBD), as this is currently one of the most well researched cases of a causal relationship between the microbiome and disease state. Dysbiosis and Disease state Disruption of the gut flora is associated with painful inflammation of the gastrointestinal tract, diagnosed as IBD. Crohn’s disease and Ulcerative Colitis are conditions under the umbrella term of IBD and cause painful swelling and eventually ulcers in the gastrointestinal tract. The exact cause of IBD remains unclear, with the true cause likely a combination of genetics, environmental factors and the gut microbiome. Evidence has come to light that shows a link between disease state and the gut dysbiosis, where they influence each other and are potentially both each other’s cause and effect. Successfully treating IBD has proved difficult; medications focus on alleviating inflammation or other symptoms as antibiotics have shown limited effectiveness in curing the disease. Antibiotics have even been suggested to weaken the immune system long-term, as evidence suggests that antibiotic clearance of commensal bacteria can provide opportunity for pathogenic strains to establish themselves. Medical treatments destabilizing the microbiome can lead to a change in overall metabolism and chronic Clostridium difficile infection. When colonization resistance is compromised there is more opportunity for single bacteria to dominate the community, with antibiotic-associated diarrhoea a common side effect associated with antibiotic induced dysbiosis. Microbial-based therapies Recently potential therapies pivoted to target the microbiota, as reinstating a healthy colony of gut microbials should alleviate the cause of IBD. Previous treatments relied on antibiotics followed by a course of probiotics; however, this has had variable levels of success as the antibiotic treatment can further reduce bacterial diversity in the gut. Probiotics have limited effectiveness in alleviating symptoms; any effect is transient as no probiotic microbial strains are detectable after 2 weeks of stopping intake. In modern clinical trials we have already seen positive results from microbiome treatments in clearing C. difficile infection, such as faecal microbiota transplantation (FMT) therapy. FMT uses faeces from a healthy donor, which are processed and delivered to the gastrointestinal tract of patients. Faeces contain a high microbial load, with up to 1011 bacterium per gram and multiple archaea, fungi and viruses that could not be delivered orally in a probiotic form. Success in resolving dysbiosis through FMT is variable but shows more promise than other therapies. Future Potential Specific forms of IBD such as ulcerative colitis (UC) was first treated with FMT in 1989, with patients reducing medications within a week of enema treatments and remaining clinically disease free for multiple years after treatment. More recent trials have had more variable levels of remission, suggesting donor compatibility, disease prevalence and engraftment of the microbiota all factor into the success of FMT. There is potential in this therapy, as FMT has proved more robust than previous treatments for IBD. Modern research into the relationship between disease and gut flora has come a long way in a relatively short time and shows there is much potential for future research in this area. Written by Charlotte Jones Related articles: the power of probiotics / Crohn's disease / the dopamine connection / Diverticular disease / Nanoparticles on gut health / Microbes in charge Project Gallery

The tireless challenge Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Childhood stunting in developing countries 10/07/25, 10:16 Last updated: Published: 09/03/24, 17:53 The tireless challenge Introduction Certain countries worldwide face numerous challenges that decrease their populations' quality of life; some include hunger, poverty and rising harmful emissions, which are complicated to resolve. This is because international cooperation is needed to tackle them effectively. Furthermore, they are associated with stunting, defined as diminished growth and development that children experience because of undernutrition or lack of sufficient nutrients, frequent infections and deficient psychosocial interventions, according to the World Health Organisation. With this definition in mind, this article will delve into stunting and malnutrition before discussing how stunting is linked to infectious diseases and harmful emissions and steps forward to reduce this condition in developing countries, as shown in Figure 2 . Undernutrition and stunting Stunting is one of the consequences of undernutrition, possibly due to reduced synthesis of insulin-like growth factor 1 (IGF-1) in the body, leading to amplified growth hormone (6). As for the determinants of undernutrition, a paper from Brazil found socioeconomic characteristics like family income and biological ones such as age notably linked to undernutrition. Another result of undernutrition is being underweight. A systematic review from Ethiopia focusing on nutrition in 5-year-old children amalgamated 18 studies. It estimated that stunting and being underweight had 42% and 33% prevalence, respectively; it could be inferred that undernutrition is linked to stunting. Additionally, a paper that used data from 32 Sub-Saharan African countries discovered that providing maternal health insurance (MHI) reduces stunting and being underweight, which is more apparent in girls than boys. In turn, MHI is necessary for supporting children’s health. Non-nutritional factors and stunting As for infections and stunting, an article highlighted that children with stunted growth are vulnerable to diarrhoeal and respiratory diseases besides malaria. Moreover, conditions worsen undernutrition, causing a vicious cycle between them, manifesting into growth defects. Furthermore, a systematic review of 80 studies found a connection between helminth infections and stunting, but insufficient evidence supported this hypothesis. With this said, there may need to be additional studies to investigate this further. With undernutrition’s impact on the immune system, newborns and small children with extreme protein deficiency have smaller thymuses and underdeveloped peripheral lymphoid organs, leading to immunological cell defects such as reduced T-cell count. Before concluding this article, exposure to harmful emissions is a recurring problem that affects everyone, including children. Different observational studies proposed that inhaling nitrogen oxide and particulate matter in utero could modify DNA methylation, possibly influencing foetal growth. Conclusion Reflecting on all the evidence in this article, stunting in developing countries is heading in a direction where it could become problematic. However, according to findings from UNICEF, stunting has gradually reduced between 2000 and 2020 in children under 5 years old. Nevertheless, awareness of stunting in developing countries is critical because it is the first step to tackling this health issue. Written by Sam Jarada Related articles: Childhood obesity / Depression in children / Postpartum depression in adolescent mothers REFERENCES Jamali D, Leigh J, Samara G, Barkemeyer R. Grand challenges in developing countries: Context, relationships, and logics. Business Ethics, the Environment & Responsibility. 2021 Sep;30(S1):1–4. Maleta K. Undernutrition. Malawi medical journal: the journal of Medical Association of Malawi. 2006 Dec;18(4):189–205. World Health Organization. Stunting in a nutshell. www.who.int . 2015 Nov;19. Beal T, Tumilowicz A, Sutrisna A, Izwardy D, Neufeld LM. A review of child stunting determinants in Indonesia. Maternal & Child Nutrition. 2018 May 17;14(4):e12617. Vaivada T, Akseer N, Akseer S, Somaskandan A, Stefopulos M, Bhutta ZA. Stunting in childhood: an overview of global burden, trends, determinants, and drivers of decline. The American Journal of Clinical Nutrition. 2020 Aug 29;112. Soliman A, De Sanctis V, Alaaraj N, Ahmed S, Alyafei F, Hamed N, et al. Early and Long-term Consequences of Nutritional Stunting: From Childhood to Adulthood. Acta Bio Medica : Atenei Parmensis. 2021;92(1) Correia LL, Silva AC e, Campos JS, Andrade FM de O, Machado MMT, Lindsay AC, et al. Prevalence and determinants of child undernutrition and stunting in semiarid region of Brazil. Revista de Saúde Pública. 2014 Feb 1;48:19–28. Abdulahi A, Shab-Bidar S, Rezaei S, Djafarian K. Nutritional status of under five children in Ethiopia: a systematic review and meta-analysis. Ethiopian Journal of Health Sciences. 2017 Mar 15;27(2):175. Kofinti RE, Koomson I, Paintsil JA, Ameyaw EK. Reducing children’s malnutrition by increasing mothers’ health insurance coverage: A focus on stunting and underweight across 32 sub-Saharan African countries. Economic Modelling. 2022 Dec 1;117:106049. Vonaesch P, Tondeur L, Breurec S, Bata P, Nguyen LBL, Frank T, et al. Factors associated with stunting in healthy children aged 5 years and less living in Bangui (RCA). Wieringa F, editor. PLOS ONE. 2017 Aug 10;12(8):e0182363. Raj E, Calvo-Urbano B, Heffernan C, Halder J, Webster JP. Systematic review to evaluate a potential association between helminth infection and physical stunting in children. Parasites & Vectors. 2022 Apr 20;15(1). Schaible UE, Kaufmann SHE. Malnutrition and Infection: Complex Mechanisms and Global Impacts. PLoS Medicine. 2007 May 1;4(5):e115. Sinharoy SS, Clasen T, Martorell R. Air pollution and stunting: a missing link? The Lancet Global Health. 2020 Apr;8(4):e472–5. UNICEF. Malnutrition in Children. UNICEF DATA. 2023. Project Gallery

How they're used in treatments Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A new model: miniature organs in biomedicine 23/10/25, 10:21 Last updated: Published: 16/10/23, 21:39 How they're used in treatments Introduction Within biomedicine, the study of diseases and understanding their mechanisms are crucial to the treatments we can develop for them. Before a treatment option can be rolled out to the general public, it must be tested for safety and efficacy. Usually, this testing takes place in the form of cell cultures or animal models. However, these methods cannot always accurately replicate the human body's complexity and physiological responses and are sometimes quite expensive and difficult to maintain. In the past few years, a new model has come to light known as organoids, allowing for a new realm of understanding into drug development, disease, and human biology. What Are Organoids? Organoids are self-organised, small, three-dimensional organ models which allow scientists and researchers to study different biological organs and tissues in a lab setting, including their physiological functions, development, and structure. These miniature organs are remarkable in their resemblance to actual organs and are obtained from stem cells, and they can undergo division to become any cell type. From their theoretical abilities, organoids may be able to serve utmost value in biomedicine and how we think about testing new treatments. Disease Modelling, Drug Development and Personalised Medicine One of the ways in which organoids can be used is to model diseases and test for potential drug targets and treatment programmes. In this way, researchers can replicate congenital and acquired conditions, such as cystic fibrosis and cancer, to study key target phenotypes and understand disease progression, which can help identify potential drug targets. From here, the efficacy of these therapeutics can be assessed quite quickly under different circumstances. As an example of this being used currently, scientists involved in cancer research have produced organoids from tumour cells stemming from cancer patients. These patient-derived organoids have been made for various cancers, including endometrium. They will allow for the ability to test chemotherapy drugs and determine which are most effective for individual patients whilst factoring in comorbidities and other unique factors to that person. Through this personalised approach, it is hoped that therapeutics will allow for a customised treatment programme which lowers the risk of side effects and improves the quality of care. Understanding Development and Function Another use of organoids is going into more depth and exploring our understanding of how an organ may develop and function. Using organoids can help us observe how different cells may work together and interact to organise themselves, allowing researchers to strengthen their knowledge of organogenesis by mimicking the natural growth conditions of the human environment. By combining tissue engineering with an appreciation of an organ's functional and developmental processes, organoid use can be extended to regenerative medicine to help fill research gaps in the molecular and cellular mechanisms of tissue regeneration. Techniques such as ELISA and immunofluorescent staining can help garner these critical details. By achieving this, organoids may produce entire organs for transplantation, addressing the organ donor shortage and lowering the risk of donor rejection. Recent Breakthroughs Cardiovascular diseases are one of the leading causes of death around the world. The human heart is limited to regenerating damaged tissue; thus, research must explore using organoids and other cell-based therapies to encourage natural repair processes. By investigating this avenue, cardiomyocytes derived from human pluripotent stem cells are a promising source. These cell types have the potential to restore contractile functions in animal models as well as the ability to regenerate myocardial tissue. Researchers have developed a cardiac organoid with silicon nanowires that have significantly improved the medicinal efficacy of stem cell-derived cardiac organoids. Using these nano-wired organoids, electrical activity was shown to improve, which in turn supported improved contractility in ischemia-injured mice. Challenges and Future Directions While the promising nature of organoids must be acknowledged, they are not without limitations. Research is currently ongoing to improve the reproducibility and scalability of organoids and their cultures to make organoids more accessible and their use more widespread. Below are some summarised advantages and disadvantages of organoids. Conclusion In conclusion, the advent of organoids has created a revolutionary era within the scope of biomedicine. These miniature organs have remarkable potential in various research, development, and tissue engineering facets. Organoids provide scientists with precise modelling of diseases across a range of different organs, assuring their versatility. From understanding organ development to combating cardiovascular diseases and introducing personalised treatment for cancer patients, it is unclear why they are being more rapidly explored. While they hold their promise, there are still challenges surrounding their reproducibility, restricting them from being used in organ transplantation. However, with ongoing progress, organoids undoubtedly have the aptitude to tailor treatments and address complexities of tissue regeneration, heralding a groundbreaking era in healthcare. Written by Irha Khalid Related article: iPSCs and organoids / Animal testing ethics Project Gallery

How chemistry plays a part Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The role of chemistry in space exploration 14/07/25, 15:00 Last updated: Published: 05/08/23, 09:41 How chemistry plays a part Background Space exploration is without a doubt one of the most intriguing areas of science. As humans, we have a natural tendency to investigate everything around us – with space, the main question we want to answer is if there is life beyond us on Earth. Astronomers use advanced telescopes to help look for celestial objects and therefore study their structures, to get closer in finding a solution to this question. However, astronomers do have to communicate with other scientists in doing so. After all, the field of science is all about collaboration. One example is theoretical physicists studying observed data and, as the name suggests, come up with theories using computational methods for other scientists to examine experimentally. In this article, we will acknowledge the importance of chemistry in space exploration, from not only studying celestial bodies but also to life support technology for astronauts and more. Examples of chemistry applications 1) Portable life support systems To survive in space requires advanced and well-designed life support systems due to being exposed to extreme temperatures and conditions. Portable life support systems (PLSS) are devices connected to an astronaut’s spacesuit that supplies oxygen as well as removal of carbon dioxide (CO2). The famous apollo lunar landing missions had clever PLSS – they utilised lithium hydroxide to remove CO2 and liquid cooling garments, which used any water to remove heat from breathing air. However, these systems are large and quite bulky, so hopefully we can see chemistry help us design even more smart PLSS in the future. 2) Solid rocket propulsion systems Chemical propellants in rockets eject reaction mass at high velocities and pressure using a source of fuel and oxidiser, causing thrust in the engine. Simply put, thrust is a strong force that causes an object to move – in this case, a rocket launching into space. Advancements in propellant chemistry has allowed greater space exploration to take place due to more efficient and reliable systems. 3) Absorption spectroscopy Electromagnetic radiation is energy travelling at the speed of light (approx. 3.0 x 108 m/s!) that can interact with matter. This radiation consists of different wavelengths and frequencies, with longer wavelengths possessing shorter frequencies and vice versa. Each molecule has unique absorption wavelength(s) – this means that if specific wavelengths of radiation ‘hits’ a substance, electrons in the ground state will become excited and can jump up to higher energy states. A line appears in the absorption spectrum for every excited electron (see Figure 1 ). As a result, spectroscopic analysis of newly discovered planets or moons can give us information on the different elements that are present. It should also be noted that the excited electrons will relax back down to the ground state and emit a photon, allowing us to observe emission spectra as well. In the emission spectra, the lines would be in the exact same place as those in the absorption, but coloured in a black background (see Figure 2 ). Fun fact: There are six essential elements needed for life – carbon, hydrogen, nitrogen, oxygen, phosphorus and sulfur. In 2023, scientists concluded that Saturn’s moon Enceladus has all these which indicates that life could be present here! 1) Space medicine Whilst many people are fascinated by the idea of going to space, it is definitely not an easy task as the body undergoes more stress and changes than one can imagine. For example, barotrauma is when tissues filled with air space due to differences in pressure between the body and ambient atmosphere becomes injured. Another example is weakening of the immune system, as researchers has been found that pre-existing T cells in the body were not able to fight off infection well. However, the field of space medicine is growing and making sure discomforts like those above are prevented where possible. Space medicine researchers have developed ‘countermeasures’ for astronauts to follow, such as special exercises that maintain bone/muscle mass as well as diets. Being in space is isolating which can cause mental health problems, so early-on counselling and therapy is also being provided to prevent this. To conclude Overall, chemistry plays a vital role in the field of space exploration. It allows us to go beyond just analysis of celestial objects as demonstrated in this article. Typically, when we hear the word ‘chemistry’ we often just think of its applications in the medical field or environment, but its versatility should be celebrated more often. Written by Harsimran Kaur Related articles: AI in space / The role of chemistry in medicine / Astronauts in space Project Gallery